William Charles O'neill Iv, MD | |
1365 Clifton Rd Ne Bldg B, The Emory Clinic - Nephrology, Atlanta, GA 30322-1013 | |
(404) 778-4366 | |
Not Available |
Full Name | William Charles O'neill Iv |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 45 Years |
Location | 1365 Clifton Rd Ne Bldg B, Atlanta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215049648 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 28056 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Emory University Hospital | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol - virtually unknown to the public - may be the most serious cardiovascular health threat of all. Scientists from China presented one of the first studies on the cholesterol-boosting effects of oxycholesterol here today at the 238th National Meeting of the American Chemical Society. The researchers hope their findings raise public awareness about oxycholesterol, including foods with the highest levels of the substance and other foods that can combat oxycholesterol's effects.
Indiana University scientists have solved a perplexing mystery regarding one of the body's main energy storage molecules, in the process shedding light on a possible route to treatment of a rare but deadly disease in teenagers.
Three top Walter and Eliza Hall Institute researchers have been recognised for their contributions to Australian medical research, with their election as fellows of the Australian Academy of Health and Medical Sciences.
› Verified 7 days ago
Entity Name | The Emory Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol - virtually unknown to the public - may be the most serious cardiovascular health threat of all. Scientists from China presented one of the first studies on the cholesterol-boosting effects of oxycholesterol here today at the 238th National Meeting of the American Chemical Society. The researchers hope their findings raise public awareness about oxycholesterol, including foods with the highest levels of the substance and other foods that can combat oxycholesterol's effects.
Indiana University scientists have solved a perplexing mystery regarding one of the body's main energy storage molecules, in the process shedding light on a possible route to treatment of a rare but deadly disease in teenagers.
Three top Walter and Eliza Hall Institute researchers have been recognised for their contributions to Australian medical research, with their election as fellows of the Australian Academy of Health and Medical Sciences.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
William Charles O'neill Iv, MD 1365 Clifton Rd Ne Bldg B, The Emory Clinic - Nephrology, Atlanta, GA 30322-1013 Ph: (404) 778-4366 | William Charles O'neill Iv, MD 1365 Clifton Rd Ne Bldg B, The Emory Clinic - Nephrology, Atlanta, GA 30322-1013 Ph: (404) 778-4366 |
News Archive
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol - virtually unknown to the public - may be the most serious cardiovascular health threat of all. Scientists from China presented one of the first studies on the cholesterol-boosting effects of oxycholesterol here today at the 238th National Meeting of the American Chemical Society. The researchers hope their findings raise public awareness about oxycholesterol, including foods with the highest levels of the substance and other foods that can combat oxycholesterol's effects.
Indiana University scientists have solved a perplexing mystery regarding one of the body's main energy storage molecules, in the process shedding light on a possible route to treatment of a rare but deadly disease in teenagers.
Three top Walter and Eliza Hall Institute researchers have been recognised for their contributions to Australian medical research, with their election as fellows of the Australian Academy of Health and Medical Sciences.
› Verified 7 days ago
Khadeja Jamilia Johnson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1800 Howell Mill Rd Nw Ste 275, Atlanta, GA 30318 Phone: 404-756-1290 | |
Dr. Matthew J. Wilson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 755 Mt Vernon Hwy, Suite 530, Atlanta, GA 30328 Phone: 404-252-7970 Fax: 404-250-0553 | |
Kajal Patel, M.D, M.P.H Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1525 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-2700 | |
Dr. Earl Stewart Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2850 Paces Ferry Rd Se Ste 460, Atlanta, GA 30339 Phone: 678-556-4950 | |
Mary E. Bergh, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 980 Johnson Ferry Rd Ste 520, Atlanta, GA 30342 Phone: 404-303-3320 Fax: 404-303-3464 | |
John J Doran, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne Bldg A, The Emory Clinic - Nephrology, Atlanta, GA 30322 Phone: 404-778-5380 | |
Frank A Anania, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1365 Clifton Rd Ne Ste B1266, The Emory Clinic - Gastroenterology, Atlanta, GA 30322 Phone: 404-778-3184 |